Drug Development News

Recent Posts

Orphalan Touts First FDA-Approved Wilson’s Disease Treatment Since 1970
May 23, 2022
IDEAYA Biosciences Receives Orphan Drug Designation for Darovasertib, a PKC Inhibitor, for the Treatment of Uveal Melanoma
May 20, 2022
Rare Disease Highlight: Charcot-Marie-Tooth Disease
May 19, 2022
SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors
May 18, 2022
Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR™ T Cell Product Candidate, for the Treatment of Multiple Myeloma
May 16, 2022

Archives

Categories